Nasdaq

Medtronic Introduces MiniMed™ Mio™ Advance Infusion Set Enabling Fewer Insertion Steps for People with Diabetes in the U.S.

DUBLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today introduced the MiniMed™ Mio™ Advance infusion set to all Medtronic insulin pump ...
Diabetes.co.uk

Minimed Mio Advance Infusion Set launched to make pump insertion easier

A device designed to make inserting insulin pump infusion sets easier has been made available in Europe. The MiniMed Mio Advance Infusion Set, unveiled at a recent diabetes conference in Vienna, comes ...
Business Wire

Capillary Biomedical Receives FDA Approval to Begin Pivotal Trial of Its SteadiFlow Seven-Day-Wear Infusion Set Technology

IRVINE, Calif.--(BUSINESS WIRE)--Medical device developer Capillary Biomedical, Inc. (CapBio) has announced that it has received investigational device exemption (IDE) approval from the U.S. Food and ...
FierceBiotech

Medtronic begins US launch of 7-day insulin infusion set

The thin plastic tubing of infusion sets that connect insulin pumps to the body typically need to be changed every two or three days—but a new version in the U.S. more than doubles that timespan. The ...
Nasdaq

Medtronic InPen™ Real-World Data and Extended Infusion Set* Pivotal Trial Results Demonstrate Strong Clinical Outcomes and Positive User Experience

DUBLIN, June 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced key clinical data from the virtual 81st annual American Diabetes Association ...
Business Wire

Capillary Biomedical Reports Best-in-Class Clinical Feasibility Results for its SteadiFlow Seven-Day-Wear Infusion Set Technology at ADA Scientific Sessions

IRVINE, Calif.--(BUSINESS WIRE)--Medical device developer Capillary Biomedical, Inc. (CapBio) has presented highly favorable clinical feasibility study results for its SteadiFlow cannula technology at ...
Healio

Extended-wear insulin infusion set lasts 7 days for most wearers, with few adverse events

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A novel extended-wear insulin infusion set was usable ...
Los Angeles Business Journal

Promising Clinical Feasibility Results for Seven-Day-Wear Infusion Set Technology Announced

Medical device developer Capillary Biomedical, Inc. (CapBio) has presented highly favorable clinical feasibility study results for its SteadiFlow cannula technology at this year’s American Diabetes ...
FierceBiotech

FDA clears BD insulin infusion set developed with diabetes patient advocacy groups

Becton Dickinson ($BDX) worked with diabetes patient advocate groups to develop its latest insulin infusion set, which is designed for improved insulin flow with ...
PR Newswire

BD and Medtronic Collaborate to Introduce a New Infusion Set with BD FlowSmart™ Technology Designed to Improve Insulin Pump Therapy

BOSTON, June 8, 2015 /PRNewswire/ -- BD Medical, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), and Medtronic (NYSE: MDT) today announced a ...
Reuters

Medtronic Introduces Minimed Mio Advance Infusion Set Enabling Fewer Insertion Steps For People With Diabetes In U.S.

Bank of America has hired four veteran technology bankers as it looks to expand its market share in tech dealmaking, according to two internal memos seen by Reuters. Reuters, the news and media ...